Gain of oncogenic function of p53 mutants regulates E-cadherin expression uncoupled from cell invasion in colon cancer cells
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Mutations in the p53 tumour suppressor gene are associated clinically with tumour progression and metastasis. Downregulation of the E-cadherin cell-cell adhesion molecule is a key event for epithelial to mesenchymal transition (EMT) in tumour progression. Here, we show that wild-type p53 induced to adopt a mutant conformation, and hot-spot p53 mutants, which are both transcriptionally inactive, downregulate E-cadherin expression in the colon carcinoma cell line HCT116. Downregulation of E-cadherin occurred concomitantly with the upregulation of Slug and Zeb-1, transcriptional factors known to repress E-cadherin gene expression. In addition, knockdown of Slug and Zeb-1 expression diminished p53-mediated E-cadherin repression. Knocking down endogenous mutant p53 in MDA-MB-231 and SW620 cancer cell lines lacking E-cadherin protein restored the expression of E-cadherin. Complete loss of E-cadherin expression in HCT116 cells induced morphological alterations along with upregulation of vimentin, a mesenchymal marker. These changes characteristic of the EMT phenotype were, however, not sufficient to confer invasiveness in a three-dimensional matrix. Downregulation of E-cadherin by mutant p53 was not required to promote the invasive phenotype induced by inactivation of p53. These findings indicate that independent control of E-cadherin expression and cell motility could be essential molecular events in p53 mutant-induced invasive phenotypes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506 · cited 1×
“In addition, p53 controls its own activity via transactivation of E3 ubiquitin-protein ligase Mdm2 (known as Hdm2 in humans), which mediates the ubiquitylation and proteasomal degradation of p53 (Haupt et al., 1997; Kubbutat et al., 1997).”
BackgroundRegulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312 · cited 1×
“In addition, p53 controls its own activity via transactivation of E3 ubiquitin-protein ligase Mdm2 (known as Hdm2 in humans), which mediates the ubiquitylation and proteasomal degradation of p53 (Haupt et al., 1997; Kubbutat et al., 1997).”
BackgroundSnail, Zeb and bHLH factors in tumour progression: An alliance against the epithelial phenotype?
Peinado, H., Olmeda, D., & Cano, A. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2131 · Cited by 3,121
Requirement for p53 and p21 to Sustain G 2 Arrest After DNA Damage
Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J. P., Sedivy, J. M., Kinzler, K. W., & Vogelstein, B. (1998) · Science · doi:10.1126/science.282.5393.1497 · Cited by 2,803 · cited 2×
“(Bunz et al., 1998)], and HCT116-shp53 cells, in which p53 expression was knocked-down with a retroviral vector expressing a p53-directed short hairpin RNA (shp53).”
BackgroundMethodVleminckx, K., Vakaet, L., Mareel, M., Fiers, W., & Van Roy, F. (1991) · Cell · doi:10.1016/0092-8674(91)90143-m · Cited by 1,656
Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome
Olive, K. P., Tuveson, D. A., Ruhe, Z. C., Yin, B., Willis, N. A., Bronson, R. T., Crowley, D., & Jacks, T. (2004) · Cell · doi:10.1016/j.cell.2004.11.004 · Cited by 1,308 · cited 1×
“Indeed, tumours emerging from mutant-p53 knock-in mice display aggressive and metastatic traits that are never detected in tumours developing in a p53-deficient mice (Lang et al., 2004; Olive et al., 2004).”
BackgroundGain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome
Lang, G. A., Iwakuma, T., Suh, Y.-A., Liu, G., Rao, V. A., Parant, J. M., Valentin-Vega, Y. A., Terzian, T., Caldwell, L. C., Strong, L. C., et al. (2004) · Cell · doi:10.1016/j.cell.2004.11.006 · Cited by 1,069 · cited 1×
“Indeed, tumours emerging from mutant-p53 knock-in mice display aggressive and metastatic traits that are never detected in tumours developing in a p53-deficient mice (Lang et al., 2004; Olive et al., 2004).”
BackgroundAssessing TP53 status in human tumours to evaluate clinical outcome
Soussi, T., & Béroud, C. (2001) · Nature reviews. Cancer · doi:10.1038/35106009 · Cited by 659
Derksen, P. W. B., Liu, X., Saridin, F., van der Gulden, H., Zevenhoven, J., Evers, B., van Beijnum, J. R., Griffioen, A. W., Vink, J., Krimpenfort, P., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.09.013 · Cited by 591 · cited 1×
“Nevertheless, loss of both E-cadherin and p53 resulted in the accelerated development of invasive and metastatic mammary carcinomas in mice (Derksen et al., 2006).”
Backgroundp53 controls cancer cell invasion by inducing the MDM2-mediated degradation of Slug
Wang, S.-P., Wang, W.-L., Chang, Y.-L., Wu, C.-T., Chao, Y.-C., Kao, S.-H., Yuan, A., Lin, C.-W., Yang, S.-C., Chan, W.-K., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1875 · Cited by 493 · cited 1×
“A recent report demonstrating that p53 induces Mdm2-mediated Slug degradation, a known repressor of E-cadherin gene expression (Wang et al., 2009); prompted us to test whether inactivation of p53 had an effect on the epithelial phenotype.”
Cited by
Mutant p53 in Cancer: New Functions and Therapeutic Opportunities
Muller, P. A. J., & Vousden, K. H. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.01.021 · Cited by 1,545
“…Adorno et al., 2009 R175H, R273H 10(3) stable/transient Gloushankova et al., 1997 R248Q HEC-1 endogenous Dong et al., 2012 R273H SW620 endogenous Roger et al., 2010 R175H, G245S, R248W, R273H MCF10Ab stable/transient Zhang et al., 2011 Polyploidy V143A NHF3 cellsb stable/transient Gualberto et…”
Zlobec, I., & Lugli, A. (2010) · Oncotarget · doi:10.18632/oncotarget.199 · Cited by 331
Epithelial-mesenchymal Transition and Cell Invasion
Son, H.-J., & Moon, A. (2010) · Toxicological Research · doi:10.5487/tr.2010.26.4.245 · Cited by 320
The rebel angel: mutant p53 as the driving oncogene in breast cancer
Walerych, D., Napoli, M., Collavin, L., & Del Sal, G. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs232 · Cited by 289
Mutant p53–associated myosin-X upregulation promotes breast cancer invasion and metastasis
Arjonen, A., Kaukonen, R., Mattila, E., Rouhi, P., Högnäs, G., Sihto, H., Miller, B. W., Morton, J. P., Bucher, E., Taimen, P., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci67280 · Cited by 178
“A large body of evidence indicates that mutant p53 promotes cell migration, epithelial-to-mesenchymal transition, and metastasis (18–23).”
Metadata
- Authors
- Roger, L., Jullien, L., Gire, V., & Roux, P.
- Venue
- Journal of Cell Science
- Publisher
- The Company of Biologists
- Published
- 2010-04-15
- Volume
- 123
- Issue
- 8
- Pages
- 1295-1305
- ISSN
- 0021-9533 (ISSN-L)
- 1477-9137
- OpenAlex
- W2097420405
- Cited by
- 105
- References
- 11
- FWCI
- 3.28
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Gain of oncogenic function of p53 mutants regulates E-cadherin expression uncoupled from cell invasion in colon cancer cells. https://app.cochat.ai/papers/10.1242/jcs.061002
- The paper
- Roger, L., Jullien, L., Gire, V., & Roux, P. (2010). Gain of oncogenic function of p53 mutants regulates E-cadherin expression uncoupled from cell invasion in colon cancer cells. Journal of Cell Science. https://doi.org/10.1242/jcs.061002
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.